Supply of Truseq compatible Duplex Y adaptors
The Royal Marsden NHS Foundation TrustcontractFind a Tender ↗Ref ocds-h6vhtk-055db5Procurement Act 2023SME suitableVCSE suitablepending
Estimated value
—
Awarded value
£665k
Suppliers
1
Lots
1
1 awarded
Published
11 Jul 2025
Description
The Laboratory at RMH is currently using these DNA adaptors for high throughput sequencing experiments. These reagents are required to deliver a service. The adaptors have been validated for tests that RMH offers as part of the Molecular Diagnostic service and are incorporated into Standard Operating Procedures.
Scope
- Reference
- ocds-h6vhtk-055db5
- Commercial tool
- Standalone contract
- Particular suitability
- Small and medium-sized enterprises (SME)Voluntary, community and social enterprises (VCSE)
Submission & procedure
- Procedure
- Direct award
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£665k
Award date
—
Contract start
03 Aug 2025
Contract end
03 Aug 2026
Awarded to
Awarded suppliers· 1 supplier
Awarded — · Contract period 03 Aug 2025 — 03 Aug 2026
Award value
£665k
Other contracts from The Royal Marsden NHS Foundation Trust
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Integrated DNA Technologies· 8
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Supply of Truseq compatible Duplex Y adaptors | contract | — | 07 Nov 2025 |
| Integrated DNA | contract | — | 04 Nov 2025 |
| Supply of Truseq compatible Duplex Y adaptors | contract | — | 17 Jul 2025 |
| Supply of Truseq compatible Duplex Y adaptors | contract | — | 11 Jul 2025 |
| Cancer Reagents Service | contract | — | 01 Jul 2025 |
| UK Research and Innovation - Oligonucleotide Synthesis and Nucleic Acid Sequencing Services Framework | contract | — | 25 Jun 2024 |
| UKHSA-Scientific-IDT Primers for Financial Year 2023-24 | contract | £50k | 13 Jul 2023 |
| UK SBS RE18190 Oligonucleotide Synthesis and DNA Sequencing Services | call off | £2.0m | 03 May 2019 |